These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30421050)

  • 1. ASO Author Reflections: Rate of Axillary Lymph Node Dissection has Decreased in Patients Treated with Neoadjuvant Systemic Therapy.
    Nguyen TT; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):693-694. PubMed ID: 30421050
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Tailoring of Targeted Axillary Dissection-Intraoperative Nodal Evaluation Reduces Second Operations.
    Wu S; Liu G
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):634-635. PubMed ID: 30411270
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Avoiding an Axillary Lymph Node Dissection: The Benefit of Neoadjuvant Chemotherapy for Occult Primary Breast Cancer.
    Botty van den Bruele A; Plitas G; Pilewskie M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):865-866. PubMed ID: 32725524
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted axillary dissection and sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy - a retrospective study.
    Coufal O; Zapletal O; Gabrielová L; Fabian P; Schneiderová M
    Rozhl Chir; 2018; 97(12):551-557. PubMed ID: 30646734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
    Piltin MA; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
    [No Abstract]   [Full Text] [Related]  

  • 6. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection.
    van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB
    Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):848-849. PubMed ID: 32696307
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Moving Forward De-escalation of Axillary Surgery After Neoadjuvant Treatment in Breast Cancer.
    Rubio IT
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):638-639. PubMed ID: 30284130
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Improving Patient Selection for Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Kantor O; James TA
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):640-641. PubMed ID: 30302645
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sentinel lymph node biopsy and neoadjuvant treatment in breast cancer].
    Duraes M; Guillot E; Seror J; Pouget N; Rouzier R
    Bull Cancer; 2017 Oct; 104(10):892-901. PubMed ID: 28890124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASO Author Reflections: Reducing Axillary Lymph Node Dissections in Node-Positive Breast Cancer Patients.
    van der Noordaa MEM; Vrancken Peeters MTFD
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):677-678. PubMed ID: 30474766
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Exploring Discordant Response to Neoadjuvant Therapy in Breast Cancer: Insights into the Clinical and Biological Implications of Persistent Lymph Node Metastasis.
    James TA; Roldan E
    Ann Surg Oncol; 2023 Dec; 30(13):8464-8465. PubMed ID: 37821788
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
    Kantor O; King TA
    Ann Surg Oncol; 2021 Mar; 28(3):1368-1369. PubMed ID: 33389297
    [No Abstract]   [Full Text] [Related]  

  • 14. Validation of sentinel lymph node biopsy in breast cancer women N1-N2 with complete axillary response after neoadjuvant chemotherapy. Multicentre study in Tarragona.
    Carrera D; de la Flor M; Galera J; Amillano K; Gomez M; Izquierdo V; Aguilar E; López S; Martínez M; Martínez S; Serra JM; Pérez M; Martin L
    Rev Esp Med Nucl Imagen Mol; 2016; 35(4):221-5. PubMed ID: 26848141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
    Castelo M; Scheer AS
    Ann Surg Oncol; 2020 Aug; 27(8):2677-2678. PubMed ID: 32206953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M
    Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
    Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
    Lee SB; Yu JH; Park H; Kim HJ; Park SH; Chae BJ; Youn HJ; Jung SY; Kim EK; Jung YS; Son BH
    Asian J Surg; 2019 Jan; 42(1):314-319. PubMed ID: 30049563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node biopsy after neoadjuvant chemotherapy: a new standard for patients with axillary metastases?
    Morrow M; Dang CT
    JAMA; 2013 Oct; 310(14):1449-50. PubMed ID: 24100931
    [No Abstract]   [Full Text] [Related]  

  • 20. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.